KRISHAN BATRA: Open Payments
NPI 1518021336 · ODESSA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,885 in 23 payments from 10 companies in 2025. Trend: 2023 $1,072 · 2024 $1,884 · 2025 $1,885
Food & beverage: $1,885
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $594 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $332 |
| Axsome Therapeutics, Inc. | 2 | $247 |
| E.R. Squibb & Sons, L.L.C. | 3 | $224 |
| ABBVIE INC. | 2 | $127 |
| Alkermes, Inc. | 1 | $122 |
| Vanda Pharmaceuticals Inc. | 1 | $115 |
| Neurocrine BioSciences, Inc. | 2 | $74 |
| Corium, LLC | 1 | $26 |
| Indivior Inc. | 1 | $24 |
Products named: AUSTEDO XR, CAPLYTA, Auvelity, COBENFY, UZEDY, VRAYLAR, LYBALVI, FANAPT.
Industry payments across FL — which companies pay providers there.
